J E Westlin - JoVE Visualize

Showing results (11-20 of 51) with videos related to

Pageof 6

Sort By:

Acta Oncologica (Stockholm, Sweden)|January 1, 1996

99mTc-dextran-antibody conjugates. Labelling proceduresM Márquez, J E Westlin, S Nilsson, et al.

Anticancer Research|July 25, 1998

Pain figures are unsuitable for determination of palliative radiotherapy portals in patients with hormone refractory prostatic cancerK M Kälkner, J E Westlin, S Nilsson, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1993

Characterization and uptake of radiolabelled meta-iodobenzylguanidine (MIBG) in a human neuroblastoma heterotransplant model in athymic ratsS Nilsson, S Påhlman, H Arnberg, et al.

Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997

Comparison between transversal SPECT, 3-dimensional rendering and 3-dimensional rendering plus clipping in the diagnosis of somatostatin receptor distribution in malignancies using 111In-DTPA-D-Phe1-octreotide scintigraphyK M Kälkner, S Nilsson, J Ylä-Jääski, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1993

Three-dimensional OctreoScan111 SPECT of abdominal manifestation of neuroendocrine tumoursJ E Westlin, H Ahlström, J Ylä-Jääski, et al.

Cancer Research|June 11, 1998

Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodiesE T Janson, M Stridsberg, A Gobl, et al.

Acta Oncologica (Stockholm, Sweden)|June 25, 1999

In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complexA Lukinius, U Ohrvall, J E Westlin, et al.

Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000

[111In-DPTA-D-Phe1]-octreotide scintigraphy in the management of patients with advanced renal cell carcinomaM Edgren, J E Westlin, K M Kälkner, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000

Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumorsE T Janson, J E Westlin, U Ohrvall, et al.

Acta Endocrinologica|October 1, 1993

Large somatostatin-insensitive thyrotrophin-secreting pituitary tumour responsive to D-thyroxine and dopamine agonistsF A Karlsson, P Burman, O Kämpe, et al.

Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:

Pageof 6

Acta Oncologica (Stockholm, Sweden)|January 1, 1996

99mTc-dextran-antibody conjugates. Labelling proceduresM Márquez, J E Westlin, S Nilsson, et al.

Anticancer Research|July 25, 1998

Pain figures are unsuitable for determination of palliative radiotherapy portals in patients with hormone refractory prostatic cancerK M Kälkner, J E Westlin, S Nilsson, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1993

Characterization and uptake of radiolabelled meta-iodobenzylguanidine (MIBG) in a human neuroblastoma heterotransplant model in athymic ratsS Nilsson, S Påhlman, H Arnberg, et al.

Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997

Comparison between transversal SPECT, 3-dimensional rendering and 3-dimensional rendering plus clipping in the diagnosis of somatostatin receptor distribution in malignancies using 111In-DTPA-D-Phe1-octreotide scintigraphyK M Kälkner, S Nilsson, J Ylä-Jääski, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1993

Three-dimensional OctreoScan111 SPECT of abdominal manifestation of neuroendocrine tumoursJ E Westlin, H Ahlström, J Ylä-Jääski, et al.

Cancer Research|June 11, 1998

Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodiesE T Janson, M Stridsberg, A Gobl, et al.

Acta Oncologica (Stockholm, Sweden)|June 25, 1999

In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complexA Lukinius, U Ohrvall, J E Westlin, et al.

Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000

[111In-DPTA-D-Phe1]-octreotide scintigraphy in the management of patients with advanced renal cell carcinomaM Edgren, J E Westlin, K M Kälkner, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000

Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumorsE T Janson, J E Westlin, U Ohrvall, et al.

Acta Endocrinologica|October 1, 1993

Large somatostatin-insensitive thyrotrophin-secreting pituitary tumour responsive to D-thyroxine and dopamine agonistsF A Karlsson, P Burman, O Kämpe, et al.

Pageof 6